Utilizing CGM systems that alert patients of downward trends in blood glucose may prevent hypoglycemia.132 Patients without access to CGM but who use insulin or oral hypoglycemic agents should test their blood glucose frequently using a structured SMBG regimen. The gene discussed is INS; the disease is Hypoglycemia.